Tourette syndrome associated with mental retardation: A single-subject treatment study with haloperidol

Peter B. Rosenquist, James W. Bodfish, Rebekah Thompson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A Tic Checklist and direct observation tic measurement procedure were developed for the assessment of Tourette syndrome in individuals with mental retardation. Using a single-subject reversal design, we applied this assessment method to the evaluation of haloperidol treatment for a subject with Tourette syndrome and severe mental retardation. Relative to baseline, haloperidol 10 mg/day produced decreases of 66% in simple motor tics, 46% in complex motor tics, 45% in simple vocal tics, and 50% in complex vocal tics. Improvement was also seen in careprovider ratings of tic severity, hyperactivity, and compulsive behaviors.

Original languageEnglish (US)
Pages (from-to)497-504
Number of pages8
JournalAmerican Journal on Mental Retardation
Volume101
Issue number5
StatePublished - Mar 1 1997

Fingerprint

Tics
Tourette Syndrome
Haloperidol
Intellectual Disability
measurement procedure
rating
evaluation
Compulsive Behavior
Mental Retardation
Syndrome
Checklist
Observation
Evaluation
Rating
Hyperactivity

ASJC Scopus subject areas

  • Education
  • Rehabilitation
  • Developmental and Educational Psychology
  • Health Professions(all)

Cite this

Tourette syndrome associated with mental retardation : A single-subject treatment study with haloperidol. / Rosenquist, Peter B.; Bodfish, James W.; Thompson, Rebekah.

In: American Journal on Mental Retardation, Vol. 101, No. 5, 01.03.1997, p. 497-504.

Research output: Contribution to journalArticle

@article{df05167020cb416a8f5e859c6387efbc,
title = "Tourette syndrome associated with mental retardation: A single-subject treatment study with haloperidol",
abstract = "A Tic Checklist and direct observation tic measurement procedure were developed for the assessment of Tourette syndrome in individuals with mental retardation. Using a single-subject reversal design, we applied this assessment method to the evaluation of haloperidol treatment for a subject with Tourette syndrome and severe mental retardation. Relative to baseline, haloperidol 10 mg/day produced decreases of 66{\%} in simple motor tics, 46{\%} in complex motor tics, 45{\%} in simple vocal tics, and 50{\%} in complex vocal tics. Improvement was also seen in careprovider ratings of tic severity, hyperactivity, and compulsive behaviors.",
author = "Rosenquist, {Peter B.} and Bodfish, {James W.} and Rebekah Thompson",
year = "1997",
month = "3",
day = "1",
language = "English (US)",
volume = "101",
pages = "497--504",
journal = "American Journal on Intellectual and Developmental Disabilities",
issn = "1944-7515",
publisher = "American Association on Intellectual and Developmental Disabilities",
number = "5",

}

TY - JOUR

T1 - Tourette syndrome associated with mental retardation

T2 - A single-subject treatment study with haloperidol

AU - Rosenquist, Peter B.

AU - Bodfish, James W.

AU - Thompson, Rebekah

PY - 1997/3/1

Y1 - 1997/3/1

N2 - A Tic Checklist and direct observation tic measurement procedure were developed for the assessment of Tourette syndrome in individuals with mental retardation. Using a single-subject reversal design, we applied this assessment method to the evaluation of haloperidol treatment for a subject with Tourette syndrome and severe mental retardation. Relative to baseline, haloperidol 10 mg/day produced decreases of 66% in simple motor tics, 46% in complex motor tics, 45% in simple vocal tics, and 50% in complex vocal tics. Improvement was also seen in careprovider ratings of tic severity, hyperactivity, and compulsive behaviors.

AB - A Tic Checklist and direct observation tic measurement procedure were developed for the assessment of Tourette syndrome in individuals with mental retardation. Using a single-subject reversal design, we applied this assessment method to the evaluation of haloperidol treatment for a subject with Tourette syndrome and severe mental retardation. Relative to baseline, haloperidol 10 mg/day produced decreases of 66% in simple motor tics, 46% in complex motor tics, 45% in simple vocal tics, and 50% in complex vocal tics. Improvement was also seen in careprovider ratings of tic severity, hyperactivity, and compulsive behaviors.

UR - http://www.scopus.com/inward/record.url?scp=0030975989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030975989&partnerID=8YFLogxK

M3 - Article

C2 - 9083606

AN - SCOPUS:0030975989

VL - 101

SP - 497

EP - 504

JO - American Journal on Intellectual and Developmental Disabilities

JF - American Journal on Intellectual and Developmental Disabilities

SN - 1944-7515

IS - 5

ER -